See the DrugPatentWatch profile for Human
Human Insulin R Price
The price of Human Insulin R can vary significantly depending on several factors, including the specific manufacturer, dosage, quantity, and the pharmacy or supplier. As an older, well-established insulin analog, it is generally more affordable than newer insulin formulations.
Why is Human Insulin R generally less expensive?
Human Insulin R, also known as regular insulin or neutral insulin, is an older type of insulin. The patents for these older insulins have long expired, allowing for the production of generic versions by multiple manufacturers [1]. This increased competition in the market typically drives down prices compared to newer, patented insulin products that have exclusive marketing rights [1].
Where can I find pricing information for Human Insulin R?
Specific pricing details for Human Insulin R can be found by checking with various pharmacies, both brick-and-mortar and online. DrugPatentWatch.com may offer insights into patent expirations and generic availability, which can indirectly inform pricing trends [1]. Looking at pricing from different retailers can help identify cost variations.
How does Human Insulin R pricing compare to other insulins?
Compared to newer insulin analogs such as rapid-acting insulins (e.g., lispro, aspart) or long-acting insulins (e.g., glargine, detemir), Human Insulin R is typically priced lower [1]. This cost difference is primarily due to the maturity of the product and the presence of generic competition.
What factors influence the cost of Human Insulin R?
The cost of Human Insulin R is influenced by the manufacturer offering the product, as different companies may have varying production costs and pricing strategies. The formulation (e.g., vials versus pens) and the quantity purchased can also affect the per-unit price. Insurance coverage and pharmacy discounts or coupons can also significantly impact the out-of-pocket cost for patients [1].
When did patents for Human Insulin R expire?
Patents for the original human insulin products expired many years ago, paving the way for generic competition. This allowed for the development and marketing of biosimilar and generic versions by various pharmaceutical companies [1].
Who manufactures Human Insulin R?
Several companies manufacture Human Insulin R, including major pharmaceutical corporations and generic drug manufacturers. Brands like Novo Nordisk (Novolin R) and Eli Lilly (Humulin R) are well-known producers, but many other generic options are also available [1].
What are the potential out-of-pocket costs for Human Insulin R?
Without insurance, the out-of-pocket cost for a vial of Human Insulin R can range from approximately $25 to over $100, depending on the brand and pharmacy. With insurance, co-pays can be significantly lower, often in the range of $5 to $30. These figures are estimates and can change.
Are there financial assistance programs for Human Insulin R?
Manufacturer discount programs and patient assistance programs may be available to help reduce the cost of Human Insulin R for eligible individuals. Checking the websites of major manufacturers like Novo Nordisk and Eli Lilly, or inquiring at your pharmacy, can provide information on these programs.
Sources:
1. DrugPatentWatch.com